In established tumors, classic Ly6C+ monocytes migrate to tumors in a C-C chemokine receptor-2 (CCR2)-dependent manner and mainly differentiate into tumor-associated macrophages, which contribute to tumor progression, metastasis formation and therapy resistance [17]. Here, CCR2 is linked to neoplasm.